Many of these genes, such as aflatoxin B 1 aldehyde reductase member 2 (AKR7A2), v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (LYN), or cytochrome b reductase 1 (CYP1B1) have not been reported in prior studies of endometrial cancer and thus provide novel potential targets for diagnosis and treatment. The gene discussed is AKR7A2; the disease is endometrial cancer.